BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The National Drug Abuse Treatment Clinical Trials Network - Northeast Node - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
X-ORIGINAL-URL:https://www.ctnnortheastnode.org
X-WR-CALDESC:Events for The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220601T120000
DTEND;TZID=America/New_York:20220601T130000
DTSTAMP:20260502T120325
CREATED:20220527T143814Z
LAST-MODIFIED:20220527T143814Z
UID:2911-1654084800-1654088400@www.ctnnortheastnode.org
SUMMARY:SNMA Guest Speaker - Dr. Nathan Chomilo - Race and Health Equity
DESCRIPTION:To access this webinar\, CLICK HERE. \nPresenter:  Nathan T. Chomilo (MD\, FAAP\, FACP)\, Medical Director\, MN Medicaid & MinnesotaCare; Adjunct Assistant Professor of Pediatrics-University of Minnesota Medical School; Executive Committee Member – Section on Minority Health Equity & Inclusion\, American Academy of Pediatrics \nDescription: Racism is passive; anti-racism is active. This webinar will cover ‘how we can move from awareness of racism to action against it as clinicians\, starting in early childhood.’
URL:https://www.ctnnortheastnode.org/event/snma-guest-speaker-dr-nathan-chomilo-race-and-health-equity/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220602T140000
DTEND;TZID=America/New_York:20220602T150000
DTSTAMP:20260502T120325
CREATED:20220512T174701Z
LAST-MODIFIED:20220512T174701Z
UID:2826-1654178400-1654182000@www.ctnnortheastnode.org
SUMMARY:CSC Basics: Family Psychoeducation and Support
DESCRIPTION:Are you new to working with individuals with early psychosis? Are you interested in learning more about what early psychosis coordinated specialty care is all about? \nCoordinated specialty care for early psychosis is an evidence-based treatment model aimed at fostering resilience and recovery for individuals who have experience a first episode of psychosis or are at clinical high risk for developing psychosis. Each webinar will be co-presented by a professional with expertise in that component of care\, as well as an individual with lived experience who can speak to how this aspect of care was meaningful in their journey towards recovery. This series is geared towards any individuals that are new to working on an Early Psychosis Specialty Team – including students\, clinicians\, prescribers\, supported employment specialists\, family clinicians\, and peer specialists. \nThe content from these webinars will be recorded and used for the development of an online course aimed at helping to provide a basic orientation to new staff and trainees that are beginning to work in a coordinated specialty program for individuals experiencing early psychosis. The series will happen once per month starting in February\, on the first Thursday of each month at 2 PM ET (11 AM PT). \nPresenter: Susan Gingerich \nRegister Here
URL:https://www.ctnnortheastnode.org/event/csc-basics-family-psychoeducation-and-support/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220603T120000
DTEND;TZID=America/New_York:20220603T130000
DTSTAMP:20260502T120325
CREATED:20220526T130122Z
LAST-MODIFIED:20220526T181923Z
UID:2896-1654257600-1654261200@www.ctnnortheastnode.org
SUMMARY:Opioid Facts and Figures
DESCRIPTION:Presenter: Lauran Wirf\, DO\, Addiction Medicine Fellow University of Colorado School of Medicine\, Denver \nCost: No Fee \nTarget audience: This activity is designed for for Nurses\, MAT Team Providers\, Addictions Specialists\, SUD Project Directors\, Managers\, and Facilitators. This activity is accredited for nurses. \nCredit Designations Available: Nursing CE \nWebinar description: With the increasing prevalence of illicit fentanyl\, it is important for healthcare providers to understand the new hurdles they may face in treatment of opioid use disorders. This session aims to improve the healthcare provider’s understanding of the changing trends of illicit opioids that they may see in their patient population. This will provide information on pharmacokinetics and how fentanyl may differ from other opioids and will touch base on treatment modalities. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nExplain the pharmacokinetics of Opioids.\nDiscuss the change in trends of illicit opioids.\nExamine various treatment modalities.\n\nCredit education information: This course has been approved by the California Board of Registered Nursing\, provider #CEP16785\, for a maximum of 1.00 Nursing CE. The licensee must retain this document for a period of four (4) years after the course concludes. \nRegister Now
URL:https://www.ctnnortheastnode.org/event/opioid-facts-and-figures/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220603T130000
DTEND;TZID=America/New_York:20220603T140000
DTSTAMP:20260502T120325
CREATED:20220527T165451Z
LAST-MODIFIED:20220527T165451Z
UID:2919-1654261200-1654264800@www.ctnnortheastnode.org
SUMMARY:An Overview of Reimbursement for MAT: Utilizing the Toolkit and Telehealth Updates
DESCRIPTION:Presenter: Joel V. Brill\, MD \nSponsor: American Society of Addiction Medicine (ASAM) \nCost: No Fee \nTarget audience: Physicians\, nurse practitioners\, physician assistants\, and other practitioners who treat and bill for insurance for patients with a substance use disorder either in-person or through telehealth. \nCredit Designations Available: AMA PRA Category 1 Credit™ \nAbout the webinar: This one-hour webinar covers professional practice gaps of addiction specialist physicians and other practitioners seeking guidance about existing billing codes that may be used to bill for services provided to patients with substance use disorder (SUD). This webinar will cover information contained in the Reimbursement for Medications for Addiction Treatment Toolkit\, information on final changes to opioid treatment programs (OTP) and relevant telehealth offerings in the Medicare program for calendar year (CY) 2022\, case studies\, billing guidance\, as well as best practices. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nDemonstrate an understanding of codes available to bill for treatment of a SUD;\nDescribe the federal changes to telehealth policies in outpatient and OTP treatment programs;\nExplain federal Medicaid policies around the treatment of SUD using telehealth;\nDescribe alternative payment model arrangements indicated for treating SUD; and\nIdentify strategies for addressing issues related to the payment of claims for the treatment of SUD.\n\n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/an-overview-of-reimbursement-for-mat-utilizing-the-toolkit-and-telehealth-updates/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220606T120000
DTEND;TZID=America/New_York:20220606T133000
DTSTAMP:20260502T120325
CREATED:20220527T142254Z
LAST-MODIFIED:20220527T142254Z
UID:2903-1654516800-1654522200@www.ctnnortheastnode.org
SUMMARY:Electronic Informed Consent Guidance: Regulatory Updates
DESCRIPTION:Conducting the informed consent process is one of the most critical tasks to be completed by a research site. It’s essential that a subject clearly understands the information and language in the consent form and that their rights\, safety\, and welfare are not jeopardized. This web seminar will review the essential language in the informed consent document through review of the FDA regulations and guidance documents\, including the December 2016 final guidance\, “Use of Electronic Informed Consent in Clinical Investigations: Questions and Answers.” Additionally\, there will be discussion of some of the challenges faced in consenting pediatric subjects in trials of greater than minimal risk\, the use of translators\, and review of the use of electronic informed consent and electronic signatures. \nParticipation in these training courses are offered on a first-come-first-serve basis. Depending on the level of responses\, there may be limited availability. \nWant to attend this training session in real time? REGISTER HERE to attend the live session. Deadline for live course registration is June 3rd\, 2022. \nNot able to make this date? CLICK HERE to register to view a recorded session. \n 
URL:https://www.ctnnortheastnode.org/event/electronic-informed-consent-guidance-regulatory-updates/
CATEGORIES:Clinical Trials Network
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220608T130000
DTEND;TZID=America/New_York:20220608T140000
DTSTAMP:20260502T120325
CREATED:20220601T204458Z
LAST-MODIFIED:20220601T204458Z
UID:2923-1654693200-1654696800@www.ctnnortheastnode.org
SUMMARY:The Special Considerations of Pain Management and Opioid Use in Older Adults
DESCRIPTION:Presenter: Mehran Mehrabi\, DMD\, MD \nSponsoring organization: American Dental Association (ADA) \nCost: No Fee \nTarget audience: Dentists\, administrative staff\, physicians\, social workers\, students and educators\, interprofessional teams \nWebinar description: Many older people have a variety of systemic diseases that have an impact on their oral health care. Analgesic medications may be part of a patient’s comprehensive treatment plan for relieving pain. \nPain management in older\, medically complex patients requires special considerations. As physiologic\, cognitive\, and social factors change\, so does the approach to patient centered management of oral healthcare. Dentists prescribing opioids for pain management has evolved but increased awareness to identify misuse\, specifically by older adults is needed. \nEducational objectives: \n\nDescribe special considerations for treating older adults\, assessing their pain and interpreting their health status.\nReview risk factors for opioid toxicity in older adults.\nReview opioid misuse in older adult population.\n\nADA CERP Recognition Statement: The ADA is a CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors\, nor does it imply acceptance of credit hours by boards of dentistry. \n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/the-special-considerations-of-pain-management-and-opioid-use-in-older-adults/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220614T120000
DTEND;TZID=America/New_York:20220614T130000
DTSTAMP:20260502T120325
CREATED:20220608T133549Z
LAST-MODIFIED:20220608T133549Z
UID:2930-1655208000-1655211600@www.ctnnortheastnode.org
SUMMARY:Dual Diagnoses of Youth Substance Use Disorders and Depression: The Nature of the Association and Treatment Implications
DESCRIPTION:Presenter: Yifrah Kaminer\, MD\, MBA\, Professor Emeritus\, Department of Psychiatry and Pediatrics\, Alcohol Research Center\, University of Connecticut School of Medicine \nSponsor: American Psychiatric Association (APA) \nCost: No Fee \nTarget audience: Interprofessional teams\, psychiatrists\, physicians\, nurses\, physician assistants. The live webinar is accredited for physicians. \nCredit Designations Available: a maximum of 1.0 AMA PRA Category 1 Credit™ \nAbout the webinar: This webinar will review the intersection of substance use disorders (SUD) and diagnosed depression within young people in the U.S. Since the mid-1990s\, Major Depressive Episodes (MDE) increased in terms of percentage and the rate of those with MDE who experience severe impairment. Additionally\, SUD presents in 3 of 10 youth experiencing MDE\, which makes this subset of youth population with co-occurring disorders (COD) at an increased risk of suicidal behavior more than due to each uni-diagnosis alone. COD have also compounding effects on personal life quality\, wellness and on response to treatment. Finally\, recent developments in interventions for youth with COD will be presented. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nExplain the five co-occurrence models to diagnosing patients who may be presenting symptoms of both conditions.\nSummarize the implications of comorbid major depressive disorder and substance use disorder to youth.\nExplain how to effectively communicate potential interventions and treatment methods to youth.\n\n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/dual-diagnoses-of-youth-substance-use-disorders-and-depression-the-nature-of-the-association-and-treatment-implications/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220627T160000
DTEND;TZID=America/New_York:20220627T170000
DTSTAMP:20260502T120325
CREATED:20220623T233758Z
LAST-MODIFIED:20220623T233758Z
UID:2938-1656345600-1656349200@www.ctnnortheastnode.org
SUMMARY:Addressing OUD in BIPOC Communities Part 3: Treatment and Recovery for Native American Populations
DESCRIPTION:Presenter: Anthony Dekker\, DO \nSponsor: National Council for Mental Wellbeing–NCMW \nContinuing education information: NOTE: The National Council for Mental Wellbeing will not be providing Continuing Medical Education credit for this event. Participants will receive a Certificate of Completion. \nTarget Audience: Interprofessional teams\, family/patients\, nurses\, physicians\, psychiatrists\, psychologists\, social workers\, students/educators \nAbout the webinar: American Indian and Alaska Native (AI/AN) communities have been deeply affected by the opioid crisis in the United States. The rate of drug overdose deaths among American Indians and Alaska Natives is well above the national average\, and 2020 data shows this trend continuing. Many Native communities also experience unique healthcare disparities that impact their access to quality\, culturally adapted substance use treatment and recovery services. This webinar will address risk factors for opioid use disorder (OUD) among AI/AN populations and effective\, prevention\, treatment and recovery strategies. \nEducational objectives: \n\nExplore the current state of drug overdose and opioid use disorder (OUD) among American Indian and Alaska Native (AI/AN) populations.\nExamine health care disparities experienced by Native populations\, including limited access to substance use disorder treatment and recovery services.\nExamine the historical/contextual issues that create barriers to treatment and negatively impact rates of OUD and opioid overdose in AI/AN populations.\nDiscuss culturally adapted public health approaches and recovery supports to increase access and engagement in treatment for Native populations.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/addressing-oud-in-bipoc-communities-part-3-treatment-and-recovery-for-native-american-populations/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220630T110000
DTEND;TZID=America/New_York:20220630T123000
DTSTAMP:20260502T120325
CREATED:20220516T165919Z
LAST-MODIFIED:20220516T165919Z
UID:2837-1656586800-1656592200@www.ctnnortheastnode.org
SUMMARY:Emergency Department-Initiated Buprenorphine for Opioid Use Disorder
DESCRIPTION:REGISTER HERE FOR THIS WEBINAR \nAbout the Webinar:\nThis webinar\, presented by Gail D’Onofrio\, MD\, will focus on the crucial role of the emergency department (ED) in recognizing and treating opioid use disorder (OUD) patients with evidence-based medications for addiction treatment. The opioid epidemic combined with the COVID-19 pandemic has greatly escalated the need to mitigate the morbidity and mortality associated with rising rates of fentanyl use. Dr. D’Onofrio will share data supporting the use of buprenorphine in the ED and discuss the consequences of not initiating treatment\, barriers to implementation of ED buprenorphine\, and components of successful integration of an ED program with community partnerships. She will also share current research by emergency physicians regarding innovative strategies like high-dose induction and use of an extended release 7-day formulation of buprenorphine.  \nLearning Objectives: \n• Evaluate at least 2 outcomes for opioid use disorder in patients receiving buprenorphine through the Emergency Department and discuss supporting evidence \n• Identify at least 2 barriers and 2 solutions to initiating buprenorphine in the Emergency Department \n• Apply at least 2 harm reduction strategies and components of the buprenorphine integration pathway \n• Propose at least 2 innovative solutions for buprenorphine induction in the ED including different formulations of buprenorphine and high dose strategies  \n1.5 CME or CE credits are available.
URL:https://www.ctnnortheastnode.org/event/emergency-department-initiated-buprenorphine-for-opioid-use-disorder-2/
END:VEVENT
END:VCALENDAR